- Advertisement -

From CRISPR Multiplexing to Pleistocene Park

George Church, PhD, sits with Kevin Davies at Harvard Medical School to sample some of the many research highlights and ethical quandaries posed by...

Risks and benefits of separating infants from COVID-19-positive mothers

Reviewed by Emily Henderson, B.Sc.Apr 12 2020 In a new commentary, Alison Stuebe, MD, President of the Academy of Breastfeeding Medicine, addresses the risks and...

UNM Researchers Uncover Mechanism of Toxic Metal Nanoparticles from MRI Scans Penetrating Human Tissue

University of New Mexico researchers have recently unveiled alarming new findings regarding gadolinium, a rare earth metal commonly used as a contrast agent in...

Global Deoxyguanosine Market 2019 – Nantong Qiuzhiyou Bioscience&biotechnology , Tuoxin Group...

Global Deoxyguanosine Market 2019 report contains wide-extending measurable details of Global Deoxyguanosine Market, which enables the customer to separate the future maneuver and anticipate...

Graduate Aptitude Test-Biotechnology, BET 2021 result declared – Hindustan Times

The National Testing Agency (NTA) has released the result of the Graduate Aptitude Test - Biotechnology (GAT – B) and Biotechnology Eligibility Test...

A new method to produce complex natural products in amoebae

A research team at the Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (Leibniz-HKI) in Jena, Germany has developed...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...

The Analytical Blueprint for Cell & Gene Therapy Success

Read NowCell and gene therapies have entered a new phase of maturity. Scientific innovation continues at an unprecedented pace, but so do the analytical...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...

The Analytical Blueprint for Cell & Gene Therapy Success

Read NowCell and gene therapies have entered a new phase of maturity. Scientific innovation continues at an unprecedented pace, but so do the analytical...

Navigating the Regulatory Labyrinth: How Biotech Leaders Are Rethinking Strategy in an Uncertain Regulatory...

There is a particular kind of anxiety that settles into a biotech boardroom when the regulatory environment becomes difficult to read. It is not...

more new items

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...

The Analytical Blueprint for Cell & Gene Therapy Success

Read NowCell and gene therapies have entered a new phase of maturity. Scientific innovation continues at an unprecedented pace, but so do the analytical...

Navigating the Regulatory Labyrinth: How Biotech Leaders Are Rethinking Strategy in...

There is a particular kind of anxiety that settles into a biotech boardroom when the regulatory environment becomes difficult to read. It is not...